Advertisement

The Economic Impact of Depression in the Workplace

  • Kyle L. GrazierEmail author
Chapter
Part of the Integrating Psychiatry and Primary Care book series (IPPC)

Abstract

There is international recognition of the high prevalence of depression and its associated disability. In countries where workers have been studied, major depressive disorders are the most prevalent chronic conditions in the prior year. Economic costs of depression include the costs related to screening, treatment, maintenance, and support of persons with depression. Costs also include those due to the effects of depression on absenteeism, presenteeism, and long-term disability costs. Workplaces offer high potential for preventing depression; recognizing early and advanced stages of depression; improving depression care off-site or on-site, in person or virtually; and improving outcomes of those efforts. Evidence-based programs for reducing depression costs exist. Innovations in technology and growing interest in financing novel programs for persons with depression offer promising outcomes clinically and economically.

Keywords

Costs of depression Workplace costs of depression 

References

  1. 1.
    World Health Organization Fact Sheet: Depression. 2017. http://www.who.int/mediacentre/factsheets/fs369/en/. Accessed 20 Feb 2018.
  2. 2.
    World Health Organization. Mental health action plan 2013–2020. Foreword. 2013. www.who.int. Accessed 6 Dec 2017.
  3. 3.
    World Health Organization. Mental health action plan 2013–2020. 2013. www.who.int. Accessed 6 Dec 2017.
  4. 4.
    Kessler RC, Merekangas KR, Wang PS. The prevalence and correlates of workplace depression in the National Comorbidity Survey Replication. J Occup Environ Med. 2008;50(4):381–90.  https://doi.org/10.1097/JOM.0b013e31816ba9b8.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Greenberg PE, Fournier AA, Sisitsky T, Pike CT, Kessler RC. The economic burden of adults with major depressive disorder in the United States (2005 and 2010). J Clin Psychiatry. 2015;76(2):155–62.  https://doi.org/10.4088/JCP.14m09298. As reported by the American Psychiatric Association Foundation Center for Workplace Mental Health. CrossRefGoogle Scholar
  6. 6.
    Weissman J, Russel D, Jay M, Beasley JM, Malaspina D, Pegus C. Disparities in health care utilization and functional limitations among adults with serious psychological distress, 2006–2014. Psychiatr Serv. 2017;68:653–9.  https://doi.org/10.1176/appi.ps.201600260.CrossRefPubMedGoogle Scholar
  7. 7.
    Razzouk D, editor. Mental health economics: the costs and benefits of psychiatric care. Basel: Springer International Publishing AG; 2017. ISBN 978-3-319-55265-1, ISBN 978-3-319-55266-8 (eBook).  https://doi.org/10.1007/978-3-319-55266-8.Google Scholar
  8. 8.
    Kessler RC. The costs of depression. Psychiatr Clin North Am. 2012;35(1):1–14.  https://doi.org/10.1016/j.psc.2011.11.005.CrossRefPubMedGoogle Scholar
  9. 9.
  10. 10.
    Chisholm D, Sweeny K, Sheehan P, Rasmussen B, Smit F, Cuijpers P, et al. Scaling-up treatment of depression and anxiety: a global return on investment analysis. Lancet Psychiatry. 2016;3(5):415–24.CrossRefGoogle Scholar
  11. 11.
    Chisholm D, Diehr P, Knapp M, Patrick D, Treglia M, Simon G. Depression status, medical comorbidity and resource costs. Evidence from an international study of major depression in primary care (LIDO). Br J Psychiatry. 2003;183:121–31.CrossRefGoogle Scholar
  12. 12.
    Stewart WF, Ricci JA, Chee E, Hahn SR, Morganstein D. Cost of lost productive work time among US workers with depression. JAMA. 2003;289(23):3135–44.CrossRefGoogle Scholar
  13. 13.
    Gabriel P, International Labour Office. Mental health in the workplace: situation analyses, United States. Geneva: Cornell University ILR School DigitalCommons@ILR; 2000.Google Scholar
  14. 14.
    Greenberg PE, Fournier AA, Sisitsky T, Pike CT, Kessler RC. The economic burden of adults with major depressive disorder in the United States (2005 and 2010). J Clin Psychiatry. 2015;76(2):155–62.  https://doi.org/10.4088/JCP.14m09298.CrossRefGoogle Scholar
  15. 15.
    Coffman J, Bates T, Geyn I, Spetz J. California’s current and future behavioral health workforce. San Francisco: The Healthforce Center at UCSF; 2018.Google Scholar
  16. 16.
    Evans-Lacko S, Knapp M. Importance of social and cultural factors for attitudes, disclosure and time off work for depression: findings from a seven country European study on depression in the workplace. PLoS One. 2014;9(3):e91053.  https://doi.org/10.1371/journal.pone.0091053.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Mark TL, Olesiuk WJ, Sherman LJ, Ali MM, Mutter R, Teich JL. Effects of the 2013 psychiatric current procedural terminology codes revision on psychotherapy in psychiatric billing. Psychiatr Serv. 2017;68(11):1197–200.  https://doi.org/10.1176/appi.ps.201700031.CrossRefGoogle Scholar
  18. 18.
    Grazier KL, Eisenberg DE, Jedele J, Smiley M. Effects of mental health parity on high utilizers: pre-post evidence from a large employer. Psychiatr Serv. 2016;67(4):448–51.  https://doi.org/10.1176/appi.ps.201400586.CrossRefPubMedGoogle Scholar
  19. 19.
    National Academies of Sciences, Engineering, and Medicine. Health-care utilization as a proxy in disability determination. Washington, DC: The National Academies Press; 2018.  https://doi.org/10.17226/24969.CrossRefGoogle Scholar
  20. 20.
    Karpansalo M, Kauhanen J, Lakka TA, Manninen P, Kaplan GA, Salonen JT. Depression and early retirement: prospective population based study in middle-aged men. J Epidemiol Community Health. 2005;59(1):70–4.CrossRefGoogle Scholar
  21. 21.
    Evans-Lacko S, Knapp M. Importance of social and cultural factors for attitudes, disclosure and time off work for depression: findings from a seven country European study on depression in the workplace. PLoS One. 2014;9(3):e91053.CrossRefGoogle Scholar
  22. 22.
    Mojtabai R, Olfson M, Sampson NA, Jin R, Druss B, Wang PS, Wells KB, Pincus HA, Kessler RC. Barriers to mental health treatment: results from the National Comorbidity Survey Replication. Psychol Med. 2011;41:1751–61.CrossRefGoogle Scholar
  23. 23.
    Rost KM. Improving depression treatment by integrated care. J Manag Care Pharm. 2005;11(3 Suppl):S5–8.PubMedGoogle Scholar
  24. 24.
    Wang PS, Simon GE, Avorn J, Azocar F, Ludman EJ, McCulloch J, Petukhova MZ, Kessler RC. Telephone screening, outreach, and care management for depressed workers and impact on clinical and work productivity outcomes: a randomized controlled trial. JAMA. 2007;298(12):1401–11.  https://doi.org/10.1001/jama.298.12.1401.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Vogel N, Schandelmaier S, Zumbrunn T, Ebrahim S, de Boer WE, Busse JW, Kunz R. Return-to-work coordination programmes for improving return to work in workers on sick leave. Cochrane Database Syst Rev. 2017;(3):CD011618. Epub 2017 Mar 30.Google Scholar
  26. 26.
    Kendrick T, El-Gohary M, Stuart B, Gilbody S, Churchill R, Aiken L, Bhattacharya A, Gimson A, Brütt AL, de Jong K, Moore M. Routine use of patient reported outcome measures (PROMs) for improving treatment of common mental health disorders in adults. Cochrane Database Syst Rev. 2016;(7):CD011119.  https://doi.org/10.1002/14651858.CD011119.pub2.
  27. 27.
    Gillies D, Buykx P, Parker AG, Hetrick SE. Consultation liaison in primary care for people with mental disorders. Cochrane Database Syst Rev. 2015; (9):CD007193.  https://doi.org/10.1002/14651858.CD007193.pub2.
  28. 28.
    Reiss-Brennan B, Brunisholz KD, Dredge C, Briot P, Grazier K, Wilcox A, Savitz L, James B. Association of integrated team-based care with health care quality, utilization, and cost. JAMA. 2016;316(8):826–34.  https://doi.org/10.1001/jama.2016.11232.CrossRefPubMedGoogle Scholar
  29. 29.
    Grazier KL, Smith JE, Song J, Smiley M. Integration of depression and primary care: barriers to adoption. J Prim Care Commun. 2014;5(1):67–73.CrossRefGoogle Scholar
  30. 30.
    Newcomb RD, Steffen MW, Breeher LE, Sturchio GM, Murad MH, Wang Z, Molella RG. Screening for depression in the occupational health setting. Occup Med (Oxford, England). 2016;66(5):390–3.  https://doi.org/10.1093/occmed/kqw043.CrossRefGoogle Scholar
  31. 31.
    Evans-Lacko S, Koeser L, Knapp M, Longhitano C, Zohar J, Kuhn K. Evaluating the economic impact of screening and treatment for depression in the workplace. Eur Neuropsychopharmacol. 2016;26:1004–13.CrossRefGoogle Scholar
  32. 32.
    Wan Mohd Yunus WMA, Musiat P, Brown JSL. Systematic review of universal and targeted workplace interventions for depression. Occup Environ Med. 2018;75:66–75. http://oem.bmj.com/CrossRefGoogle Scholar
  33. 33.
    U.S. Department of Health and Human Services (DHHS) Substance Abuse and Mental Health Services Administration (SAMHSA) Evidence-Based Practices Resource Center. https://www.samhsa.gov/ebp-resource-center. Accessed 11 Nov 2018.
  34. 34.
    U.S. Department of Health and Human Services (DHHS) SAMHSA National Registry of Evidence-Based Practices and Programs. https://www.samhsa.gov/nrepp. Accessed 27 Feb 2018.
  35. 35.
    McCance-Katz EF. The National Registry of Evidence-based Programs and Practices and SAMHSA’s new approach to implementation of evidence-based practices (EBPs). https://www.samhsa.gov/newsroom/press-announcements/201801110330.
  36. 36.
  37. 37.
    Big Data in Finance: Highlights from the Big Data in Finance Conference Hosted at the University of Michigan October 27–28, 2016. Summary Paper released February 23, 2018. Federal Office of Financial Research and the University of Michigan Center on Finance, Law and Policy.Google Scholar
  38. 38.
  39. 39.

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.School of Public Health and School of MedicineUniversity of MichiganAnn ArborUSA

Personalised recommendations